Recurrence of Glomerular Diseases (GN) After Kidney Transplantation: A Narrative Review
Journal of Clinical Medicine · 22.09.2025 · 14 (18) · 6686
DOI: 10.3390/jcm14186686 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 22.09.2025. Verfasst von Abbal Koirala und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Johns Hopkins School of Medicine, 5501 Hopkins Bayview Circle, Floor 1, Baltimore, MD 21224, USA. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Recurrence of the original glomerular disease (GN) poses a significant threat to kidney transplant function and longevity. The probability and severity of this recurrence vary, with C3 glomerulopathy and certain forms of FSGS exhibiting particularly high rates. Kidney transplant GN recurrence risk hinges on the characteristics of the initial GN, recipient/donor genetics, recipient age, donor type, end-stage kidney disease (ESRD) progression rate, and proteinuria levels. Standard immunosuppression has limited efficacy in preventing primary disease recurrence; however, agent selection and induction therapy can influence the risk for specific GNs. Diagnosing recurrent GN involves a comprehensive approach, including clinical evaluation, laboratory tests (such as proteinuria, hematuria, and specific biomarkers like anti-PLA2R for membranous nephropathy or complement for C3G), and, critically, an allograft biopsy analyzed with light, immunofluorescence, and electron microscopy. Treatment strategies are evolving towards targeted therapies, such as rituximab for antibody-mediated GN and complement inhibitors for C3G, moving away from broad immunosuppression. This narrative literature review provides practical monitoring algorithms for post-transplant settings, synthesizing information on the incidence, predictors, diagnostic strategies, and therapeutic options for various glomerular disease subtypes. The methodology involved searching MEDLINE, Embase, and Cochrane databases from 1996 to 2025, prioritizing systematic reviews, cohort studies, registries, and interventional reports. Eligibility criteria included adult transplant recipients and English-language reports on recurrent glomerular disease outcomes, excluding most single-patient case reports. Limitations include potential selection bias, omission of relevant studies, and the absence of a formal risk-of-bias assessment or meta-analysis. The evidence base is heterogeneous, with inconsistent outcome reporting and scarce randomized controlled trials. Future efforts should focus on developing predictive biomarkers, standardizing diagnostic and response criteria, conducting multicenter prospective cohorts and pragmatic trials, and creating shared registries with harmonized data.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Nephrology, Johns Hopkins School of Medicine, 5501 Hopkins Bayview Circle, Floor 1, Baltimore, MD 21224, USA.
ORCID-Profile: Abbal Koirala, Aditi Singh
Zitieren
APA
Koirala, A., Singh, A., & Geetha, D. (2025). Recurrence of Glomerular Diseases (GN) After Kidney Transplantation: A Narrative Review. Journal of Clinical Medicine, 14(18), 6686. https://doi.org/10.3390/jcm14186686
Vancouver
Koirala A, Singh A, Geetha D. Recurrence of Glomerular Diseases (GN) After Kidney Transplantation: A Narrative Review. Journal of Clinical Medicine. 2025;14(18):6686. doi:10.3390/jcm14186686
BibTeX
@article{Koirala2025,
author = {Koirala, Abbal and Singh, Aditi and Geetha, Duvuru},
title = {Recurrence of Glomerular Diseases (GN) After Kidney Transplantation: A Narrative Review},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {18},
pages = {6686},
doi = {10.3390/jcm14186686}
}
EUVIMED